J Menopausal Med.  2016 Apr;22(1):6-8. 10.6118/jmm.2016.22.1.6.

The Relevance of Women's Diseases, Jun Activation-domain Binding Protein 1 (JAB1) and p27(kip1)

• Kim M
• Kim TH
• Lee HH

• KMID: 2200913
• DOI: http://doi.org/10.6118/jmm.2016.22.1.6

Abstract

The Jun activation-domain binding protein 1 (Jab1) recognize a potential coactivator of activator protein 1 (AP-1) such as c-fos, c-jun transcription factor and the fifth subunit of the COP9 signalosome complex. Also, Jab1 activate the c-jun gene resulted cell proliferation. Not only a powerful tumor suppressor but also regulator of apoptosis negative cdk inhibitor p27(kip1) are involved in the cell cycle. This is Jab1 and p27(kip1) interact with each other, Jab1 accelerate p27(kip1) from nuclear to cytoplasm through ubiquitin/proteasome pathway. However, information about the relationship between Jab1 and p27(kip1) is not known much. Taken together, the results of this study identify function and structure of Jab1 and p27(kip1) were described in a recent article on the basis of relevant. Besides Jab1 and p27(kip1) will organize the relationship between the disease and women.

Keyword

Breast neoplasms; Cyclin-dependent kinase inhibitor p27; Endometriosis; Ovarian neoplasms

MeSH Terms

Apoptosis
Breast Neoplasms
Carrier Proteins*
Cell Cycle
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p27
Cytoplasm
Endometriosis
Female
Genes, jun
Humans
Ovarian Neoplasms
Transcription Factor AP-1
Transcription Factors
Carrier Proteins
Cyclin-Dependent Kinase Inhibitor p27
Transcription Factor AP-1
Transcription Factors

Reference

1. Chamovitz DA, Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2001; 2:96–101.

2. Schwechheimer C, Deng XW. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol. 2001; 11:420–426.

3. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999; 398:160–165.

4. Chen F, Kim E, Wang CC, Harrison LE. Ciglitazone-induced p27 gene transcriptional activity is mediated through Sp1 and is negatively regulated by the MAPK signaling pathway. Cell Signal. 2005; 17:1572–1577.

5. Zhang Q, Tian L, Mansouri A, Korapati AL, Johnson TJ, Claret FX. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett. 2005; 579:3932–3940.

6. Bloom J, Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol. 2003; 13:41–47.

7. Hsu MC, Chai CY, Hou MF, Chang HC, Chen WT, Hung WC. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Mod Pathol. 2008; 21:609–616.

8. Adler AS, Lin M, Horlings H, Nuyten DS, van de, Chang HY. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet. 2006; 38:421–430.

9. Kim TH, Lee HH, Chung SH, Park J, Lee A. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis. Arch Gynecol Obstet. 2015; 292:377–381.

10. Fedele L, Marchini M, Bianchi S, Dorta M, Arcaini L, Fontana PE. Structural and ultrastructural defects in preovulatory endometrium of normo-ovulating infertile women with minimal or mild endometriosis. Fertil Steril. 1990; 53:989–993.

11. Giudice LC, Kao LC. Endometriosis. Lancet. 2004; 364:1789–1799.

12. Wingfield M, Macpherson A, Healy DL, Rogers PA. Cell proliferation is increased in the endometrium of women with endometriosis. Fertil Steril. 1995; 64:340–346.

13. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 1998; 69:1042–1047.

14. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod. 2001; 16:1802–1808.

15. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004; 54:8–29.

16. Park JM, Kim MK. Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. J Menopausal Med. 2014; 20:14–20.

17. Lee WS, Park ES, Kim DH, Kim TH, Lee HH, Chung SH. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors. Eur J Gynaecol Oncol. 2012; 33:358–362.

18. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, et al. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res. 2001; 7:4130–4135.